Skip to main page content
Access keys NCBI Homepage MyNCBI Homepage Main Content Main Navigation

Search Page

My NCBI Filters
Results by year

Table representation of search results timeline featuring number of search results per year.

Year Number of Results
1957 3
1958 3
1959 4
1960 8
1961 1
1962 5
1965 1
1966 9
1967 14
1968 26
1969 32
1970 45
1971 64
1972 68
1973 46
1974 77
1975 65
1976 57
1977 54
1978 53
1979 63
1980 46
1981 41
1982 45
1983 50
1984 60
1985 52
1986 70
1987 59
1988 55
1989 75
1990 86
1991 84
1992 98
1993 91
1994 99
1995 76
1996 87
1997 78
1998 86
1999 113
2000 97
2001 83
2002 93
2003 112
2004 92
2005 118
2006 140
2007 164
2008 172
2009 156
2010 183
2011 251
2012 288
2013 333
2014 327
2015 405
2016 377
2017 313
2018 355
2019 276
2020 22
Text availability
Article attribute
Article type
Publication date

Search Results

6,100 results
Results by year
Filters applied: . Clear all
Page 1
A Large-scale, multicenter serum metabolite biomarker identification study for the early detection of hepatocellular carcinoma.
Luo P, Yin P, Hua R, Tan Y, Li Z, Qiu G, Yin Z, Xie X, Wang X, Chen W, Zhou L, Wang X, Li Y, Chen H, Gao L, Lu X, Wu T, Wang H, Niu J, Xu G. Luo P, et al. Hepatology. 2018 Feb;67(2):662-675. doi: 10.1002/hep.29561. Epub 2018 Jan 2. Hepatology. 2018. PMID: 28960374 Free PMC article. Clinical Trial.
Serum fibroblast growth factor 19 serves as a potential novel biomarker for hepatocellular carcinoma.
Maeda T, Kanzaki H, Chiba T, Ao J, Kanayama K, Maruta S, Kusakabe Y, Saito T, Kobayashi K, Kiyono S, Nakamura M, Ogasawara S, Suzuki E, Ooka Y, Nakamoto S, Nakagawa R, Muroyama R, Kanda T, Maruyama H, Kato N. Maeda T, et al. BMC Cancer. 2019 Nov 12;19(1):1088. doi: 10.1186/s12885-019-6322-9. BMC Cancer. 2019. PMID: 31718608 Free PMC article.
6,100 results
Jump to page
Feedback